Performing analyses of cost effectiveness, cost-of-illness analyses, analyses of impact on budget allow elaborating and gathering data about advantages of the potential product, to estimate its influence on clinical, economic and social outcomes, to analyze social significance of a disease.
Creating a clinical economic modeling and finding out its sensitivity to the value of parameters used for the modeling. This complex interdisciplinary approach makes it easier for decision-makers to adequately analyze the current state of treatment for a disease and to realize advantages of the new solution, its place in the system, priority function and use limitations.
Consultations and assisting in creating e record of cases for medicaments and medical devices for including them into restrictive lists (VED, High-Cost Diseases, regional lists). Also we do consulting on including medicaments into clinical guidelines and standards.
Analysis and expert study of the data in a therapeutic area, regulations, competitive analysis, deep study of clinical and economic data on the medicament, and creating a complex value proposition, allowing to satisfy the requirements of the outside stakeholders with maximum efficiency, including objection handling.
specialist
